汇宇制药

- 688553

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017 
汇宇制药(688553) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入53,220.2424,260.4292,707.5165,913.6845,057.47
营业收入53,220.2424,260.4292,707.5165,913.6845,057.47
二、营业总成本48,309.8221,550.2887,371.1863,648.6742,932.80
营业成本9,429.004,073.5013,044.659,504.976,622.37
营业税金及附加313.71140.72672.78443.15304.01
销售费用20,499.019,480.3836,112.0725,909.9117,543.12
管理费用3,732.412,008.027,646.095,228.533,566.47
财务费用-442.23-703.06-4,180.22-3,138.26-1,957.33
研发费用14,777.936,550.7234,075.8125,700.3816,854.16
资产减值损失----------
公允价值变动收益----644.05----
投资收益858.33235.093,418.312,060.981,414.84
其中:对联营企业和合营企业的投资收益64.83--30.6923.0056.52
汇兑收益----------
三、营业利润6,503.313,207.3112,436.856,335.965,219.83
加:营业外收入654.54586.781,206.131,061.92733.43
减:营业外支出24.5213.77427.5378.0216.88
其中:非流动资产处置损失----------
四、利润总额7,133.333,780.3313,215.457,319.855,936.38
减:所得税费用912.83-707.61-718.02-1,554.68-922.11
五、净利润6,220.504,487.9313,933.478,874.536,858.49
归属于母公司所有者的净利润6,521.344,643.5913,978.578,894.016,870.23
少数股东损益-300.84-155.66-45.11-19.48-11.74
六、每股收益
基本每股收益(元/股)0.15000.11000.33000.21000.1600
稀释每股收益(元/股)0.15000.11000.33000.21000.1600
七、其他综合收益17.316.9447.6517.1622.40
八、综合收益总额6,237.814,494.8713,981.128,891.696,880.89
归属于母公司所有者的综合收益总额6,538.654,650.5314,026.228,911.186,892.63
归属于少数股东的综合收益总额-300.84-155.66-45.11-19.48-11.74
下载全部历史数据到excel中 返回页顶